Open Access

Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2

  • Authors:
    • Qiumei Zhang
    • Dongmei Yang
  • View Affiliations

  • Published online on: December 17, 2018     https://doi.org/10.3892/etm.2018.7104
  • Pages: 1523-1528
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Emerging evidence has demonstrated the antitumor activity of allicin in various tumors. However, little study has been carried out on the functional role of allicin in cervical cancer. Our data showed that allicin suppressed cervical cancer cell viability in a time‑ and dose‑dependent manner. Allicin treatment could reverse H2O2‑induced reactive oxygen species accumulation. Meanwhile, levels of glutathione and superoxide dismutase were increased, but malondialdehyde was decreased after allicin incubation for 48 h. Furthermore, TUNEL staining showed that H2O2 treatment induced cell apoptosis, but allicin treatment could decrease cell apoptosis. Western blot assay showed that allicin could suppress the expression of nuclear factor erythroid 2‑related factor 2 (NRF2) and heme oxygenase 1. We also showed that NRF2 prompted SiHa cell proliferation and reduced SiHa cell apoptosis. More importantly, allicin‑inactivated phosphoinositide 3‑kinase/protein kinase B (PI3K/AKT) signaling could be partially reversed by overexpressing of NRF2. We also evaluated cell apoptosis in SiHa cells transfected with plasmid NRF2. Our data showed that allicin‑induced cell apoptosis (43.5±3.8%) could largely be abolished by upregulation of NRF2 (12.3±2.08%). In summary, our data showed allicin was effective in suppressing the malignant phenotype of cervical cancer cells mainly by inhibiting the expression of NRF2, showing the potential clinical benefits of allicin in cervical cancer patients.
View Figures
View References

Related Articles

Journal Cover

March-2019
Volume 17 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Q and Zhang Q: Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2. Exp Ther Med 17: 1523-1528, 2019
APA
Zhang, Q., & Zhang, Q. (2019). Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2. Experimental and Therapeutic Medicine, 17, 1523-1528. https://doi.org/10.3892/etm.2018.7104
MLA
Zhang, Q., Yang, D."Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2". Experimental and Therapeutic Medicine 17.3 (2019): 1523-1528.
Chicago
Zhang, Q., Yang, D."Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2". Experimental and Therapeutic Medicine 17, no. 3 (2019): 1523-1528. https://doi.org/10.3892/etm.2018.7104